Drug Shortage Report for RANITIDINE
Report ID | 94081 |
Drug Identification Number | 02385961 |
Brand name | RANITIDINE |
Common or Proper name | RANITIDINE |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-09-17 |
Actual start date | 2019-09-17 |
Estimated end date | Unknown |
Actual end date | 2022-08-19 |
Shortage status | Resolved |
Updated date | 2022-08-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-08-20 | English | Compare |
v5 | 2022-08-19 | French | Compare |
v4 | 2022-08-19 | English | Compare |
v3 | 2019-09-18 | English | Compare |
v2 | 2019-09-17 | French | Compare |
v1 | 2019-09-17 | English | Compare |
Showing 1 to 6 of 6